Delivery Order SPE2DB22D9239-SPE2DB25FDH74

Award Date 4/7/25
Potential Completion Date 4/28/25
Potential Value $17K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Park Ridge, IL 60068, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $32,934 contract is for the delivery of the pharmaceutical product PRIVIGEN 10% VIAL 400ML. The contract has an ultimate completion date of November 20, 2024. DMS Pharmaceutical Group holds a $499,999,999 Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB program, which...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business. The $51,376.50 contract is for the provision of PRIVIGEN 10% vial, a 200 ml pharmaceutical product. DMS Pharmaceutical Group holds a larger $499,999,999 Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB program, which enables the DLA to issue delivery orders for a comprehensive range of pharmaceutical items to support the medical...
This is a $23,975.70 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler. The order is for the supply of PRIVIGEN 10% VIAL 200ML, a specialized pharmaceutical product, with a period of performance through March 5, 2025. DMS Pharmaceutical Group holds a large Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB program, valued at $499,999,999 and valid through November...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $16,467.00 contract is for the delivery of PRIVIGEN 10% VIAL 100ML, a pharmaceutical product, and has an ultimate completion date of December 13, 2024. The contract is not associated with any set-aside designation. Additionally, DMS Pharmaceutical Group Inc. holds a $499,999,999...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract, valued at $68,502.00, is for the delivery of PRIVIGEN 10% VIAL 400ML, a pharmaceutical product. The contract has a period of performance through March 12, 2025 and does not have a set-aside designation. DMS Pharmaceutical Group Inc. holds a larger $499,999,999...
This is a firm fixed-price delivery order contract awarded to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler, by the Defense Logistics Agency (DLA). The contract, valued at $32,934.00, is for the supply of a pharmaceutical product, PRIVIGEN 10% VIAL 200ML, with a period of performance through November 5, 2024. DMS Pharmaceutical Group holds a larger indefinite delivery contract (IDC) with the DLA under the SPE2DB program, valued at up to $499,999,999, which...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $4,281.35 delivery order is for the supply of PRIVIGEN 10% VIAL 50ML, a specialized pharmaceutical product. The delivery order is part of a larger $499,999,999 Indefinite Delivery Contract (IDC) held by DMS Pharmaceutical Group with the DLA under the SPE2DB program, which covers a...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract, valued at $8,562.70, is for the delivery of PRIVIGEN 10% vial 50mL to support the medical supply needs of military healthcare facilities. The contract is not associated with any set-aside designation. DMS Pharmaceutical Group Inc. holds a $499,999,999 Indefinite...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract, valued at $13,700.40, is for the delivery of PRIVIGEN 10% VIAL 200ML, a pharmaceutical product, to support the medical supply needs of military healthcare facilities. The contract does not have a set-aside designation. DMS Pharmaceutical Group Inc. holds a larger,...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler. The $34,251.00 contract is for the supply of PRIVIGEN 10% VIAL 200ML, a specialized pharmaceutical product. DMS Pharmaceutical Group Inc. holds a $499,999,999 Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB program, which enables the DLA to issue delivery orders for a wide range of pharmaceutical items...
  • SPE2DB22D9239
    Indefinite Delivery Contract
  • SPE2DB22D9239-SPE2DB25FDH74
    Delivery Order

This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business based in Park Ridge, Illinois. The contract, valued at $17,125.50, is for the delivery of 100 ml vials of the pharmaceutical product PRIVIGEN 10%. The contract has an ultimate completion date of April 28, 2025 and does not have a set-aside designation. DMS Pharmaceutical Group Inc. is a key supplier in the federal pharmaceutical supply chain, providing a range of branded and generic prescription drugs, over-the-counter medications, biologics, and medical consumables to support the recurring medical supply needs of military healthcare facilities and veterans' medical centers. The company also holds a larger $499,999,999 Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB program, which enables the agency to issue firm fixed-price delivery orders for a comprehensive portfolio of pharmaceutical products.

Generated 7/7/25, 1:03 PM